Insights

Strategic partnerships OncoDNA has a history of collaborations with leading players and academic centers (e.g., Lilly in Italy, SYNLAB, KU Leuven) and a global partner network, suggesting sales opportunities through co-developed biomarker testing programs and integration of OncoDeep and other assays into partner workflows.

Liquid biopsy roll-out The upcoming and planned launch of fragmentomics liquid biopsy assays in Europe and beyond signals a strong opportunity to target oncology clinics, hospitals, and labs expanding non-invasive testing for therapy selection, early detection, and minimal residual disease monitoring.

Tumor profiling expansion The commercial launch of OncoXPLORE tumor-naïve molecular profiling and ongoing centralised/decentralised tissue and liquid testing capabilities position OncoDNA to address end-to-end biomarker needs, enabling cross-sell to clinics seeking comprehensive profiling and decision support.

Education and upgrade path With a suite including OncoDeep kit and robust bioinformatics reporting, there is a clear opportunity to upsell enhanced sequencing panels, data interpretation tools, and support services to laboratories expanding their in-house capabilities.

Europe-focused expansion A broad European reach through partner labs and distributors, combined with reimbursement-aware strategy support, indicates strong potential to win contracts with regional hospitals and lab networks seeking compliant, cost-effective precision oncology testing.

Similar companies to OncoDNA

OncoDNA Tech Stack

OncoDNA uses 8 technology products and services including Hotjar, Linkedin Insight Tag, iCIMS, and more. Explore OncoDNA's tech stack below.

Media & News

OncoDNA's Email Address Formats

OncoDNA uses at least 3 email formats:
OncoDNA Email FormatsExamplePercentage
F.Last@oncodna.comJ.Doe@oncodna.com
67%
First.Last@oncodna.comJohn.Doe@oncodna.com
26%
FL@oncodna.comJD@oncodna.com
7%

Frequently Asked Questions

What is OncoDNA's phone number?

Minus sign iconPlus sign icon
You can contact OncoDNA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OncoDNA's official website and social media links?

Minus sign iconPlus sign icon
OncoDNA's official website is oncodna.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does OncoDNA generate?

Minus sign iconPlus sign icon
As of October 2026, OncoDNA's annual revenue is estimated to be <$1M.

What is OncoDNA's SIC code and NAICS code?

Minus sign iconPlus sign icon
OncoDNA's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncoDNA have currently?

Minus sign iconPlus sign icon
As of October 2026, OncoDNA has approximately 52 employees across 5 continents, including Europe, North America and Africa. Key team members include Chief Data & Innovation Officer (/ Excom Member): G. G., Chief Financial Officer: V. D. C. and Chief Operations Officer: F. D. Explore OncoDNA's employee directory with LeadIQ.

What industry does OncoDNA belong to?

Minus sign iconPlus sign icon
OncoDNA operates in the Biotechnology Research industry.

What technology does OncoDNA use?

Minus sign iconPlus sign icon
OncoDNA's tech stack includes Hotjar, Linkedin Insight Tag, iCIMS, WordPress, Mailgun, Microsoft 365, OpenAI and Intercom.

What is OncoDNA's email format?

Minus sign iconPlus sign icon
OncoDNA's email format typically follows the pattern of F.Last@oncodna.com. Find more OncoDNA email formats with LeadIQ.

How much funding has OncoDNA raised to date?

Minus sign iconPlus sign icon
As of October 2026, OncoDNA has raised $29M in funding. The last funding round occurred on Mar 14, 2020 for $21M.
OncoDNA logo

OncoDNA

Biotechnology ResearchWallonia, Belgium51-200 Employees

OncoDNA is a biotechnology research company founded in 2012 and headquartered in Gosselies, Wallonia, Belgium. It focuses on genomics and theranostics, translating molecular science and digital knowledge into clinical practice to support cancer treatment, with offerings that include next generation sequencing services, biomarker testing, data analysis software, and clinical decision support tools. The OncoDNA Group is headquartered in Belgium, with BioSequence and IntegraGen based in Spain and France, and the company operates internationally through a network of distributors. Reports on workforce size vary, with some sources listing 11-50 employees and others indicating over 100 employees across multiple countries. Recent developments include the launch of OncoXPLORE and a fragmentomics liquid biopsy assay for cancer therapy selection and disease monitoring.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $29M

    OncoDNA has raised a total of $29M of funding over 2 rounds. Their latest funding round was raised on Mar 14, 2020 in the amount of $21M as a Series B.

  • <$1M

    OncoDNA's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.